Urolog. pro Praxi, 2006; 2: 47
Urolog. pro Praxi, 2006; 2: 52-54
Urinary incontinence is one of the most common medical conditions with an estimated 25 percent of the adult female population being affected. While overactive bladder is traditionally managed by pharmacotherapy, medication therapy in stress incontinence is of secondary importance. The options to clinically use alpha-adrenergic agents are limited by serious systemic adverse effects. The latest knowledge on physiology and pathophysiology of neural control of the closure apparatus function suggests, however, that pharmacotherapy might even be of use in this area.
Urolog. pro Praxi, 2006; 2: 56-59
Prostatectomy is one of the most frequent urological procedures performed in the developed world. The original open surgical approach has now been replaced by transurethral techniques. Of these the transurethral resection of the prostate (TURP) is the most common and is now being considered as the gold standard for therapy of benign prostatic hyperplasia (BPH). At the turn of 20. and 21. centuries the masive and long evolution of technologies on the prostate has brought many additional therapeutic alternatives tending to the less invasive techniques. Principles, efficacy and current indications of minimally invasive therapies of BPH are reviewed.
Urolog. pro Praxi, 2006; 2: 60-61
In children, an overactive bladder (OAB) is characterized by polakisuria, an urgent need to urinate, sometimes accompanied by urinary incontinence. Diagnosis and therapy should be initiated after micturition control has been achieved, at the age of five by the latest. Following a basic non-invasive examination to rule out neurologic and infectious causes, complex therapy may be initiated including regimen measures, behavioural therapy, early pharmacotherapy and possibly biofeedback. When three to six months of basic therapy fail, a specialized urologic investigation and further intensive treatment using alternative methods are required.
Urolog. pro Praxi, 2006; 2: 62-64
A comparison of clinical follow-up and therapeutic outcomes is not possible without all the specialists involved having a uniform „speech“. For oncologists, the unifying elements include the TNM classification of malignant tumours, staging classification and an effort to define the prognostic factors. The type and aggressivity of treatment are selected based on our knowledge of both the given and additional parameters. National registry databases allow for comparing data from large cohorts and thus for modifying the strategy of diagnosing and treatment in particular cases. Data collection and its quality are dependent upon a „mere“...
Urolog. pro Praxi, 2006; 2: 65-68
In an overview the authors concerns in treatment options of erectile and ejaculatory dysfunctions, infertility and hypotestosteronemia in men after spinal cord injury.
Urolog. pro Praxi, 2006; 2: 80-82
Urolog. pro Praxi, 2006; 2: 69-70
Urolog. pro Praxi, 2006; 2: 72-74
Urolog. pro Praxi, 2006; 2: 75-76
Urolog. pro Praxi, 2006; 2: 77-79
Urolog. pro Praxi, 2006; 2: 85-87
Urolog. pro Praxi, 2006; 2: 89-90